Cargando…

Gastroparesis with bezoar formation in patients treated with glucagon-like peptide-1 receptor agonists: potential relevance for bariatric and other gastric surgery

Detalles Bibliográficos
Autores principales:	Preda, Veronica, Khoo, Skylar Su-Yee, Preda, Tamara, Lord, Reginald V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891341/ https://www.ncbi.nlm.nih.gov/pubmed/36723995 http://dx.doi.org/10.1093/bjsopen/zrac169

Ejemplares similares

Gastric Bezoar: Cause of Weight Loss in a Patient With Previous Bariatric Surgery
por: Alemam, Ahmed, et al.
Publicado: (2021)

Gastric bezoars
por: Akbulut, Sabiye, et al.
Publicado: (2016)

Gastric bezoar
por: Sulaiman Ambusaidi, Farida Mohsin, et al.
Publicado: (2020)

A Conservative Management of Gastric Bezoar in a Novel Bariatric Procedure: Nissen-Sleeve Gastrectomy
por: Palma, Rossella, et al.
Publicado: (2022)

Reduced number of admissions with acute appendicitis but not severe acute appendicitis at two Sydney hospitals during the first COVID‐19 lockdown period
por: Al‐Abid, Meryem, et al.
Publicado: (2022)

Laparoscopic Treatment of Gastric Bezoar
por: Sharma, Deborshi, et al.
Publicado: (2010)

Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
por: Kimura, Tomohiko, et al.
Publicado: (2022)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
por: Kang, Yu Mi, et al.
Publicado: (2016)

How glucagon-like peptide 1 receptor agonists work
por: Andreasen, Christine Rode, et al.
Publicado: (2021)

SUN-543 Real World Evidence of Successful Weight Management for the Obese Population: Complete Reversal of Obesity Related Metabolic Co-Morbidities and Weight Loss in Patients Attending a Multidisciplinary Weight Management Clinic in Australia
por: Rock, Zoe, et al.
Publicado: (2020)

Association of glucagon‐like peptide‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy
por: Kobori, Toshiko, et al.
Publicado: (2023)

Association of clinically significant weight loss with number of patient visits and months of attendance at an Australian multidisciplinary weight management clinic
por: Chen, Juliana, et al.
Publicado: (2022)

Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
por: Jensen, Anders Boisen, et al.
Publicado: (2023)

Large gastric wood bezoar: Anesthesia implications
por: Karnik, Priyanka Pradeep, et al.
Publicado: (2016)

Acute Cholecystitis Masking a Gastric Bezoar
por: Chaudhry, Manahil, et al.
Publicado: (2022)

Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists
por: Zhang, Yu-Juan, et al.
Publicado: (2013)

Glucagon‐like peptide‐1 receptor agonists and their effects on weight reduction
por: Shin, Shyi‐Jang
Publicado: (2012)

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
por: Hinnen, Deborah
Publicado: (2017)

The potential of glucagon-like peptide-1 receptor agonists in heart failure
por: Kreiner, Frederik Flindt, et al.
Publicado: (2022)

Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
por: Delgado, A., et al.
Publicado: (2021)

Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management
por: Wojtara, Magda, et al.
Publicado: (2023)

Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs
por: Driessen, Johanna H. M., et al.
Publicado: (2015)

Gastric Electrical Stimulation for Gastroparesis
por: Soffer, Edy E
Publicado: (2012)

Gastroparesis
por: Miles, Matthew, et al.
Publicado: (2023)

Gastroparésie
por: Miles, Matthew, et al.
Publicado: (2023)

Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
por: Holst, Jens Juul
Publicado: (2022)

Prevalence of Hidden Gastroparesis in the Community: The Gastroparesis "Iceberg"
por: Rey, Enrique, et al.
Publicado: (2012)

Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria
por: Di Loreto, Chiara, et al.
Publicado: (2022)

Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists
por: Doggrell, Sheila A.
Publicado: (2020)

Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
por: Saraiva, Francisco Kerr, et al.
Publicado: (2014)

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
por: Gurung, Tara, et al.
Publicado: (2015)

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate
por: Lorenz, Martin, et al.
Publicado: (2017)

Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists
por: Madsbad, Sten
Publicado: (2015)

Patient preferences for glucagon-like peptide 1 receptor–agonist treatment attributes
por: Thieu, Vivian T, et al.
Publicado: (2019)

Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
por: Sawada, Noritaka, et al.
Publicado: (2020)

Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
por: Choe, Hun Jee, et al.
Publicado: (2021)

Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
por: Ja’arah, Daria, et al.
Publicado: (2021)

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
por: Baggio, Laurie L., et al.
Publicado: (2020)

Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist
por: Quadri, Hamza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mlghmj0q21s7o7qkj6s57trrut